WallStSmart

Hennessy Capital Acquisition Corp. IV (HCAC)vsOaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

OACC leads profitability with a 0.0% profit margin vs 0.0%. HCAC earns a higher WallStSmart Score of 31/100 (F).

HCAC

Avoid

31

out of 100

Grade: F

Growth: 4.3Profit: 3.5Value: 3.0Quality: 5.0

OACC

Avoid

23

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 5.8
Piotroski: 2/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HCACSignificantly Overvalued (-1864.7%)

Margin of Safety

-1864.7%

Fair Value

$0.51

Current Price

$9.92

$9.41 premium

UndervaluedFair: $0.51Overvalued

Intrinsic value data unavailable for OACC.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HCAC0 strengths · Avg: 0/10

No standout strengths identified

OACC1 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Areas to Watch

HCAC4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
2.4%4/10

2.4% earnings growth

Market CapQuality
$727.12M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

OACC4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$261.31M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : HCAC

HCAC has a balanced fundamental profile.

Bull Case : OACC

The strongest argument for OACC centers on Debt/Equity.

Bear Case : HCAC

The primary concerns for HCAC are Revenue Growth, EPS Growth, Market Cap. A P/E of 133.8x leaves little room for execution misses.

Bear Case : OACC

The primary concerns for OACC are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

OACC is growing revenue faster at 0.0% — sustainability is the question.

OACC generates stronger free cash flow (-56,521), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HCAC scores higher overall (31/100 vs 23/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Hennessy Capital Acquisition Corp. IV

FINANCIAL SERVICES · SHELL COMPANIES · USA

Hennessy Capital Acquisition Corp. IV (HCAC) is a special purpose acquisition company (SPAC) focused on identifying and merging with high-growth companies within the technology, healthcare, and consumer sectors. With an experienced management team and a commitment to enhancing shareholder value, HCAC aims to leverage its capital and strategic network to drive innovation and operational excellence in its target markets. The company is positioned to capitalize on transformative trends in the evolving marketplace, providing investors with a unique opportunity for significant returns through its acquisition strategy.

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share

FINANCIAL SERVICES · SHELL COMPANIES · USA

Oaktree Acquisition Corp. III (OACC) is a special purpose acquisition company (SPAC) focused on merging with innovative businesses within the life sciences sector. With a highly experienced management team proficient in healthcare investments, OACC aims to harness growth opportunities across various subfields, including healthcare technology, therapeutics, and medical devices. The company emphasizes strategic partnerships and robust due diligence to enhance shareholder value, while its commitment to operational excellence positions it to thrive amid the complexities of the dynamic life sciences landscape.

Visit Website →

Want to dig deeper into these stocks?